Literature DB >> 2445635

Long-term survival after vinblastine, bleomycin, and cisplatin treatment in patients with germ cell tumors of the ovary: an update.

P H Willemse1, J G Aalders, J Bouma, N H Mulder, R C Verschueren, E G de Vries, D T Sleijfer.   

Abstract

Thirteen patients with a malignant germ cell tumor of the ovary have been treated with a combination of vinblastine, bleomycin, and cisplatin (VBP). In 12 patients a complete remission was reached, which was maintained in 10 of these patients. One patient with large tumor residues and a partial remission became CR after surgery. The tumor recurred in 2 patients after 6 and 27 months. Overall, 11 of these patients are in long-term remission, from 14 to 84 months after the start of treatment. VBP is an effective treatment for malignant germ cell tumors of the ovary, even in patients with large tumor residuals.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2445635     DOI: 10.1016/0090-8258(87)90172-7

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  2 in total

1.  Reduction of the local toxicity of intraperitoneal chemotherapy; an experimental model.

Authors:  R G Molloy; B Crowley; K T Moran; M P Brady
Journal:  Ir J Med Sci       Date:  1990-06       Impact factor: 1.568

2.  Primary yolk sac tumor of the retroperitoneum: A case report and review of the literature.

Authors:  Yang-Long Guo; Ying-Li Zhang; Jian-Qing Zhu
Journal:  Oncol Lett       Date:  2014-05-22       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.